Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion : vimarsana.com

Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion

Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

London , City Of , United Kingdom , Massachusetts , United States , Cambridge , Cambridgeshire , British , Tim Wilson , David Chiswell , Andrew Calam , Zwei Rohstoff Chancen , Nick Robbins , Simon Conway , Ashley Nagle , Dave Chiswell , Lonza Biologics , Experte Carsten Stork , Elizabeth Hardaker , University Of Leeds , Business Development At Remedybio , University Of Aberdeen , King College London , B Future Health , Novartis Venture Fund , Almac Sciences , University College Cork , Epsilogen Ltd , Environmental Sciences , University Of Lincoln , Chief Business Officer , Peter Finan , Non Executive Director , Business Development , Fulcrum Pharma , Seagull Therapeutics , Chief Executive , Analytical Chemistry , Nick Robbins Cherry , Clinical Operations , Non Executive Chairman , Global Head , Respiratory Disease Area , Site Head , Novartis Institute , Biomedical Research , Executive Director , Novartis Developmental , Molecular Pathways Platform , Molecular Biology , Chief Executive Officer , Non Executive Chair , Platinum Resistant Ovarian Cancer Patients , College London , Epidarex Capital , Future Health , British Patient Capital , Schroders Capital , Managing Director ,